Cargando…
Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2)
Influenza A H7N9 virus has demonstrated considerable pandemic potential in China ever since early spring 2013. Until now, there have been no specific medicines to treat influenza A H7N9 virus infected patients. Development of a safe and effective H7N9 therapeutic preparation is urgently needed. To t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106124/ https://www.ncbi.nlm.nih.gov/pubmed/25192652 http://dx.doi.org/10.1016/j.intimp.2014.08.019 |
_version_ | 1783512553728507904 |
---|---|
author | Zhao, Zhongpeng Fan, Chuanbo Duan, Yueqiang Zhang, Liangyan Li, Min Yang, Xiaolan Li, Ruisheng Yang, Penghui Wang, Xiliang |
author_facet | Zhao, Zhongpeng Fan, Chuanbo Duan, Yueqiang Zhang, Liangyan Li, Min Yang, Xiaolan Li, Ruisheng Yang, Penghui Wang, Xiliang |
author_sort | Zhao, Zhongpeng |
collection | PubMed |
description | Influenza A H7N9 virus has demonstrated considerable pandemic potential in China ever since early spring 2013. Until now, there have been no specific medicines to treat influenza A H7N9 virus infected patients. Development of a safe and effective H7N9 therapeutic preparation is urgently needed. To this end, we prepared and evaluated the pepsin-digested F(ab′)(2) fragments of serum IgGs from the horses inoculated with a inactivated influenza A H7N9 whole virus antigens. The protective effects of the F(ab′)(2) fragments against H7N9 virus infection were determined in cultured MDCK cells by cytopathic effect (CPE) and evaluated in a BALB/c mouse model by observing death, weight loss and viral load. The in vitro results showed that the F(ab′)(2) fragments had an HI titer of 1:2048 and a neutralization titer of 1: 31,623. The in vivo assays suggested that 600U of the preparations could efficiently protect BALB/c mice from a lethal dose of A/Anhui/01/2013 (H7N9) infection even when administered two days post infection. Thus, this highly purified preparation should be a potential candidate for treating severe patients suffering from influenza A H7N9. |
format | Online Article Text |
id | pubmed-7106124 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71061242020-03-31 Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) Zhao, Zhongpeng Fan, Chuanbo Duan, Yueqiang Zhang, Liangyan Li, Min Yang, Xiaolan Li, Ruisheng Yang, Penghui Wang, Xiliang Int Immunopharmacol Article Influenza A H7N9 virus has demonstrated considerable pandemic potential in China ever since early spring 2013. Until now, there have been no specific medicines to treat influenza A H7N9 virus infected patients. Development of a safe and effective H7N9 therapeutic preparation is urgently needed. To this end, we prepared and evaluated the pepsin-digested F(ab′)(2) fragments of serum IgGs from the horses inoculated with a inactivated influenza A H7N9 whole virus antigens. The protective effects of the F(ab′)(2) fragments against H7N9 virus infection were determined in cultured MDCK cells by cytopathic effect (CPE) and evaluated in a BALB/c mouse model by observing death, weight loss and viral load. The in vitro results showed that the F(ab′)(2) fragments had an HI titer of 1:2048 and a neutralization titer of 1: 31,623. The in vivo assays suggested that 600U of the preparations could efficiently protect BALB/c mice from a lethal dose of A/Anhui/01/2013 (H7N9) infection even when administered two days post infection. Thus, this highly purified preparation should be a potential candidate for treating severe patients suffering from influenza A H7N9. Elsevier B.V. 2014-11 2014-09-02 /pmc/articles/PMC7106124/ /pubmed/25192652 http://dx.doi.org/10.1016/j.intimp.2014.08.019 Text en Copyright © 2014 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Zhao, Zhongpeng Fan, Chuanbo Duan, Yueqiang Zhang, Liangyan Li, Min Yang, Xiaolan Li, Ruisheng Yang, Penghui Wang, Xiliang Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title | Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title_full | Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title_fullStr | Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title_full_unstemmed | Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title_short | Protection from infection with influenza A H7N9 virus in a mouse model by equine neutralizing F(ab′)(2) |
title_sort | protection from infection with influenza a h7n9 virus in a mouse model by equine neutralizing f(ab′)(2) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106124/ https://www.ncbi.nlm.nih.gov/pubmed/25192652 http://dx.doi.org/10.1016/j.intimp.2014.08.019 |
work_keys_str_mv | AT zhaozhongpeng protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT fanchuanbo protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT duanyueqiang protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT zhangliangyan protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT limin protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT yangxiaolan protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT liruisheng protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT yangpenghui protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 AT wangxiliang protectionfrominfectionwithinfluenzaah7n9virusinamousemodelbyequineneutralizingfab2 |